https://scholars.lib.ntu.edu.tw/handle/123456789/537904
標題: | RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy | 作者: | Wu S.-H. Hsieh C.-C. SZU-CHUN HSU MING YAO Hsiao J.-K. Wang S.-W. CHIH-PENG LIN Huang D.-M. |
公開日期: | 2021 | 出版社: | Elsevier B.V. | 來源出版物: | Journal of Advanced Research | 摘要: | Introduction: Chemotherapeutic drugs are the main intervention for cancer management, but many drawbacks impede their clinical applications. Nanoparticles as drug delivery systems (DDSs) offer much promise to solve these limitations. Objectives: A novel nanocarrier composed of red blood cell (RBC)-derived vesicles (RDVs) surface-linked with doxorubicin (Dox) using glutaraldehyde (glu) to form Dox-gluRDVs was investigated for improved cancer therapy. Methods: We investigated the in vivo antineoplastic performance of Dox-gluRDVs through intravenous (i.v.) administration in the mouse model bearing subcutaneous (s.c.) B16F10 tumor and examined the in vitro antitumor mechanism and efficacy in a panel of cancer cell lines. Results: Dox-gluRDVs can exert superior anticancer activity than free Dox in vitro and in vivo. Distinct from free Dox that is mainly located in the nucleus, but instead Dox-gluRDVs release and efficiently deliver the majority of their conjugated Dox into lysosomes. In vitro mechanism study reveals the critical role of lysosomal Dox accumulation-mediated mitochondrial ROS overproduction followed by the mitochondrial membrane potential loss and the activation of apoptotic signaling for superior anticancer activity of Dox-gluRDVs. Conclusion: This work demonstrates the great potential of RDVs to serve a biological DDS of Dox for systemic administration to improve conventional cancer chemotherapeutics. ? 2020 |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097402456&doi=10.1016%2fj.jare.2020.11.009&partnerID=40&md5=d49a2344ee4bc0bfa5373ec76c9d423d https://scholars.lib.ntu.edu.tw/handle/123456789/537904 |
ISSN: | 2090-1232 | DOI: | 10.1016/j.jare.2020.11.009 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。